Efficacy of rhBNP in heart failure with atrial fibrillation combined with poor conventional therapy response and recurrence risk factors.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Efficacy of rhBNP in heart failure with atrial fibrillation combined with poor conventional therapy response and recurrence risk factors.
- Published In:
- American journal of translational research, 18(2), 1175-1185 (2026)
- Authors:
- Shang, Huijuan, Wang, Xiaojun, Shi, Xiaoyin, Han, Xiaoliang
- Database ID:
- RPEP-16104
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-16104APA
Shang, Huijuan; Wang, Xiaojun; Shi, Xiaoyin; Han, Xiaoliang. (2026). Efficacy of rhBNP in heart failure with atrial fibrillation combined with poor conventional therapy response and recurrence risk factors.. American journal of translational research, 18(2), 1175-1185. https://doi.org/10.62347/TGGD3922
MLA
Shang, Huijuan, et al. "Efficacy of rhBNP in heart failure with atrial fibrillation combined with poor conventional therapy response and recurrence risk factors.." American journal of translational research, 2026. https://doi.org/10.62347/TGGD3922
RethinkPeptides
RethinkPeptides Research Database. "Efficacy of rhBNP in heart failure with atrial fibrillation ..." RPEP-16104. Retrieved from https://rethinkpeptides.com/research/shang-2026-efficacy-of-rhbnp-in
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.